Evaluation of type 2 diabetes treatment with gliclazide modified release in Azerbaijan (the EdiAzer study): Results from a 16-week observational clinical study | Zendy

ValehA Mirzazada | Zendy; RamilaA Huseynova | Zendy; Shafag Mustafayeva | Zendy; FidanN Gasimova | Zendy; Ulviyya Ahmadova | Zendy; Narmin Ismayilova | Zendy; Vafa Kerimova | Zendy; Hagigat Mehdiyeva | Zendy; R.R. Suleymanova | Zendy; Zahrakhanim Maharramova | Zendy; Gulnara Iskandarli | Zendy; Ofeliya Gurbanova | Zendy; Sariyya Aghayeva | Zendy; Sabina Malikova | Zendy; Konul Ismayilova | Zendy; Khanim Salimkhanova | Zendy

Open Access

Evaluation of type 2 diabetes treatment with gliclazide modified release in Azerbaijan (the EdiAzer study): Results from a 16-week observational clinical study

Author(s) -

ValehA Mirzazada,

RamilaA Huseynova,

Shafag Mustafayeva,

FidanN Gasimova,

Ulviyya Ahmadova,

Narmin Ismayilova,

Vafa Kerimova,

Hagigat Mehdiyeva,

R.R. Suleymanova,

Zahrakhanim Maharramova,

Gulnara Iskandarli,

Ofeliya Gurbanova,

Sariyya Aghayeva,

Sabina Malikova,

Konul Ismayilova,

Khanim Salimkhanova

Publication year - 2020

Publication title -

journal of diabetology

Language(s) - English

Resource type - Journals

eISSN - 2543-3288

pISSN - 2078-7685

DOI - 10.4103/jod.jod_5_20

Subject(s) - gliclazide , medicine , metformin , glycated hemoglobin , type 2 diabetes , diabetes mellitus , overweight , clinical endpoint , adverse effect , observational study , type 2 diabetes mellitus , gastroenterology , obesity , endocrinology , clinical trial

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research